- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02242175
Efficacy of Hydrogen Breath Test in the Patients With Irritable Bowel Syndrome
Irritable bowel syndrome is characterized by abdominal discomfort and bowel habit change. It is increasing worldwide. But the pathophysiology of the irritable bowel syndrome is not proven. So, the treatment's target is the relief of the symptoms.
Small intestinal bacterial overgrowth considered as the cause of the irritable bowel syndrome. Because, it is related to the postprandial abdominal discomfort and the abdominal discomfort could be relieved after taking antibiotics. There are several diagnostic methods for small intestinal bacterial overgrowth. hydrogen breath test is non-invasive method for diagnosis of the small intestinal bacterial overgrowth. But, there is no standardized cut-off value for the hydrogen breath test. So, we want to compare the hydrogen breath test between the irritable bowel syndrome patients and normal people. And then, we want to analyze the efficacy of hydrogen breath test for the diagnosis of irritable bowel syndrome.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 120-752
- Recruiting
- Sevrance Hospital
-
Contact:
- Yong Chan Lee, MD
- Phone Number: 82-2-2228-1960
- Email: leeyc@yuhs.ac
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- over 19 years old, male and female
- normal people (control group, who has no abdominal symptoms - diarrhea, constipation etc.)
- irritable bowel syndrome patients (irritable bowel syndrome means that within the last 3 months abdominal discomfort more than three days for a month and satisfies over the below two items) 1) symptom relived after defecation 2) bowel habit change, the times of defecation changed 3) the change of the morphology of the stool
Exclusion Criteria:
- patients who do not agree for participation
- patients who have history for treatment of irritable bowel syndrome
- patients who is uncontrolled diabetes mellitus
- patients who have small bowel or large bowel diseases
- patients who had surgery for abdomen
- patients who are taking antibiotics, anti-depressants within 1 week
- patients who are taking proton pump inhibitors or opioids for analgesics
- patients who have history of bowel adhesion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: normal group
|
Glucose breath test (hydrogen breath test) is the current gold standard for diagnosis of irritable bowel syndrome.
Glucose is a sugar that will be broken down by bacteria if present in the small bowel with hydrogen or methane gas as a by-product.
The breath sample will be analyzed for hydrogen or methane content to determine if you are able to properly break down the lactose, fructose or sucrose, or if you have bacterial overgrowth.
|
|
OTHER: irritable bowel syndrome group
|
Glucose breath test (hydrogen breath test) is the current gold standard for diagnosis of irritable bowel syndrome.
Glucose is a sugar that will be broken down by bacteria if present in the small bowel with hydrogen or methane gas as a by-product.
The breath sample will be analyzed for hydrogen or methane content to determine if you are able to properly break down the lactose, fructose or sucrose, or if you have bacterial overgrowth.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The difference of H2 elevation level through the hydrogen breath test between the irritable bowel syndrome patients and the normal people
Time Frame: Within the 24 hours after 8-12 hours fasting
|
The difference of H2 elevation level through the hydrogen breath test between the irritable bowel syndrome patients and the normal people
|
Within the 24 hours after 8-12 hours fasting
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The difference of methane level through the hydrogen breath test between the irritable bowel syndrome patients and the normal people
Time Frame: Within the 24 hours after 8-12 hours fasting
|
Within the 24 hours after 8-12 hours fasting
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-2014-0046
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Irritable Bowel Syndrome
-
ProgenaBiomeWithdrawnIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome Characterized by Constipation | Irritable Bowel Syndrome Mixed | Irritable Bowel Syndrome Without Diarrhea | Irritable Bowel | Irritable Bowel Syndrome Aggravated and other conditionsUnited States
-
Universidad Autonoma de Nuevo LeonUniversidad Autonoma de Nuevo LeonEnrolling by invitationIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome MixedMexico
-
Istanbul Medipol University HospitalTepecik Training and Research Hospital; Bozyaka Training and Research Hospital and other collaboratorsRecruitingIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome MixedTurkey
-
Research and Practical Clinical Center for Diagnostics...I.M. Sechenov First Moscow State Medical UniversityEnrolling by invitationIrritable Bowel Syndrome | Irritable Bowel Syndrome - Constipation | Irritable Bowel Syndrome - Diarrhoea | Irritable Bowel Syndrome - MixedRussian Federation
-
ClasadoCR2O B.V.CompletedIrritable Bowel Syndrome | Irritable Bowel Syndrome - Constipation | Irritable Bowel Syndrome - Diarrhoea | Irritable Bowel Syndrome - MixedBelgium, Netherlands, United Kingdom
-
Md Mehedi ShahriarNot yet recruitingChronic Idiopathic Constipation | Chronic Constipation | CIC | Constipation Predominant Irritable Bowel Syndrome | Irritable Bowel Syndrome (IBS-C)Bangladesh
-
Federal Stare Budgetary Scientific Institution,...I.M. Sechenov First Moscow State Medical University; RML INVEST, Torkhovsky...CompletedIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome MixedRussian Federation
-
Dr Anthony HobsonCompletedIrritable Bowel Syndrome (IBS) | Irritable Bowel Syndrome With Diarrhea (IBS-D)United Kingdom
-
Iuliu Hatieganu University of Medicine and PharmacyNot yet recruitingIrritable Bowel Syndrome (IBS)Romania
-
Devintec SaglRecruitingIrritable Bowel Syndrome (IBS) | Irritable Bowel Syndrome of Diarrhea Type (IBS-D)Italy, Spain, France, Belgium
Clinical Trials on Glucose breath test (hydrogen breath test)
-
QOL Medical, LLCCompletedCongenital Sucrase-Isomaltase DeficiencyUnited States
-
VenterPharmaCompleted
-
Zhongshan Hospital (Xiamen), Fudan UniversityCompletedHelicobacter Pylori Infection | Gut Microbiota | Small Intestinal Bacterial Overgrowth | Metabolic ProfilesChina
-
Brain-Gut Research GroupNational University, Singapore; New Jersey Medical SchoolCompletedIrritable Bowel Syndrome | Functional Gastrointestinal DisordersSwitzerland
-
Mebo Research, Inc.Aurametrix; Menssana Research, Inc.CompletedNutritional and Metabolic DiseasesUnited States, United Kingdom
-
Imperial College LondonUniversity College London Hospitals; Northern Care Alliance NHS Foundation... and other collaboratorsRecruitingBarrett Esophagus | Oesophageal Cancer | Barretts Esophagus With DysplasiaUnited Kingdom
-
Meir Medical CenterUnknownMetabolic State, Breath Analysis, NA-Nose
-
Imperial College LondonRoyal Marsden NHS Foundation Trust; Chelsea and Westminster NHS Foundation... and other collaboratorsRecruiting
-
NHS LothianCompletedCOVID-19 | Respiratory DiseaseUnited Kingdom